Compare CFG & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CFG | IQV |
|---|---|---|
| Founded | 1828 | 1982 |
| Country | United States | United States |
| Employees | 17398 | 93000 |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7B | 28.6B |
| IPO Year | N/A | 2013 |
| Metric | CFG | IQV |
|---|---|---|
| Price | $63.03 | $168.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 16 |
| Target Price | $70.17 | ★ $227.13 |
| AVG Volume (30 Days) | ★ 3.3M | 1.6M |
| Earning Date | 04-16-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.86% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | N/A | ★ 1.61 |
| Revenue | N/A | ★ $9,739,000,000.00 |
| Revenue This Year | $20.17 | $6.77 |
| Revenue Next Year | $8.30 | $5.89 |
| P/E Ratio | ★ $16.85 | $104.62 |
| Revenue Growth | N/A | ★ 41.60 |
| 52 Week Low | $39.40 | $137.33 |
| 52 Week High | $68.79 | $247.05 |
| Indicator | CFG | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 51.56 | 46.35 |
| Support Level | $58.09 | $159.08 |
| Resistance Level | $66.24 | $172.80 |
| Average True Range (ATR) | 1.42 | 7.14 |
| MACD | -0.10 | -0.24 |
| Stochastic Oscillator | 52.36 | 44.08 |
Citizens Financial Group Inc is a bank holding company headquartered in Providence, Rhode Island. Through its subsidiaries, it offers various retail and commercial banking products and services to individuals, small businesses, middle-market companies, large corporations, and institutions. The group's reportable business segments are: Consumer Banking and Commercial Banking. The majority of its revenue is generated from the Consumer Banking segment, which serves consumer customers and small businesses, offering traditional banking products and services, including deposits, mortgage and home equity lending, credit cards, small business loans, education loans, point-of-sale finance loans, and wealth management solutions, among others, through a network of branches and ATMs.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.